CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 4 Gift EXECUTIVE CHAIRMAN gave 6,000 shares (gift)
- 4 Planned sale CEO AND PRESIDENT sold 1,273 shares at $413.31 ($526,144)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $414.22 ($1,242,645)
- 4 Planned sale Director sold 18,064 shares at an average $388.01 ($7,008,972)
- 4 Gift PRESIDENT, CLINICALDIAGNOSTICS gave 945 shares (gift)
- 4 Planned sale Director sold 9,150 shares at an average $351.49 ($3,216,145)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 102,000 shares at an average $341.15 ($34,797,271)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 50,000 shares at an average $327.97 ($16,398,267)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 18,160 shares at an average $325.88 ($5,917,907)
- 4 Planned sale CEO AND PRESIDENT sold 1,698 shares at $320.99 ($545,041)
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 6,517 shares at $321.53 ($2,095,411)
- 4 Planned sale Director sold 6,000 shares at $325.32 ($1,951,942)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 2,000 shares at $320.90 ($641,800)
- 4 Planned sale Director sold 9,150 shares at an average $315.66 ($2,888,325)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 795 shares at an average $271.74 ($216,030)
- 4 Planned sale CEO AND PRESIDENT sold 3,076 shares at an average $266.39 ($819,431)
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 295 shares at $267.99 ($79,057)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,410 shares at an average $265.58 ($905,627)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 334 shares at $267.99 ($89,508)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 731 shares at $267.99 ($195,900)
Page 2 of 64 · 1,274 filings